We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$28B
1-Year Est. Return
44.22%
This Fund
S&P 500
This Quarter
Est. Return
+34.77%
1 Year Est. Return
+44.22%
3 Year Est. Return
+129.23%
5 Year Est. Return
+202.08%
10 Year Est. Return
–
AUM
$1.54B
AUM Growth
-$138M
(-8.2%)
Cap. Flow
+$260M
Cap. Flow
% of AUM
16.88%
Top 10 Holdings %
Top 10 Hldgs %
9.99%
Holding
2,498
New
653
Increased
404
Reduced
598
Closed
777
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CY
Cypress Semiconductor
CY
|
+$17M |
| 2 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$15M |
| 3 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$14.8M |
| 4 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$11.6M |
| 5 |
CZR
Caesars Entertainment Corporation
CZR
|
+$11.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.77M |
| 2 |
Cigna
CI
|
+$2.57M |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.48M |
| 4 |
Baidu
BIDU
|
+$2.2M |
| 5 |
Bausch Health
BHC
|
+$2.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 74.67% |
| 2 | Healthcare | 6.24% |
| 3 | Technology | 5.14% |
| 4 | Consumer Discretionary | 4.16% |
| 5 | Communication Services | 1.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CALL
AbbVie
ABBV
$453B
| $26.6M | 1.72% |
300,100
+54,400
| +22% | +$4.52M |
|
2
Axsome Therapeutics
AXSM
$10.8B
| $17.6M | 1.14% |
+170,268
| New | +$6.88M |
|
3
CALL
IQVIA
IQV
$44.1B
| $17M | 1.1% |
110,100
+24,700
| +29% | +$3.61M |
|
|
CY
4
DELISTED
Cypress Semiconductor
CY
| $17M | 1.1% |
+727,918
| New | +$17M |
|
|
WBC
5
DELISTED
WABCO HOLDINGS INC.
WBC
| $15M | 0.97% |
+110,884
| New | +$15M |
|
|
ZAYO
6
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $15M | 0.97% |
+432,147
| New | +$14.8M |
|
|
CZR
7
DELISTED
Caesars Entertainment Corporation
CZR
| $12.4M | 0.81% |
+912,836
| New | +$11.6M |
|
|
MLNX
8
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $11.9M | 0.77% |
+101,868
| New | +$11.6M |
|
|
AGN
9
DELISTED
Allergan plc
AGN
| $11.8M | 0.77% |
+61,711
| New | +$11.1M |
|
10
CALL
Bread Financial
BFH
$4.26B
| $9.58M | 0.62% |
107,006
+100,365
| +1,511% | +$8.86M |
|
11
CALL
Amgen
AMGN
$236B
| $9.21M | 0.6% |
38,200
-54,700
| -59% | -$12.1M |
|
|
WCG
12
DELISTED
Wellcare Health Plans, Inc.
WCG
| $8.88M | 0.58% |
+26,882
| New | +$8.07M |
|
|
ACIA
13
DELISTED
Acacia Communications Inc
ACIA
| $8.67M | 0.56% |
127,852
+127,558
| +43,387% | +$8.45M |
|
14
PUT
McDonald's
MCD
$181B
| $8.26M | 0.54% |
41,800
+38,900
| +1,341% | +$7.72M |
|
15
CALL
Johnson & Johnson
JNJ
$663B
| $8.24M | 0.53% |
56,500
-30,400
| -35% | -$4.12M |
|
|
ADSW
16
DELISTED
Advanced Disposal Services Inc
ADSW
| $7.77M | 0.5% |
+236,366
| New | +$7.75M |
|
|
MDCO
17
DELISTED
Medicines Co
MDCO
| $7.71M | 0.5% |
+90,809
| New | +$6.06M |
|
18
PUT
Constellation Brands
STZ
$21.9B
| $7.61M | 0.49% |
40,100
+37,200
| +1,283% | +$7.02M |
|
|
GRUB
19
CALL
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $7.51M | 0.49% |
77,200
+30,950
| +67% | +$2.83M |
|
20
CALL
Zoetis
ZTS
$31.3B
| $7.32M | 0.47% |
55,300
-44,900
| -45% | -$5.58M |
|
21
CALL
DXC Technology
DXC
$1.86B
| $7.08M | 0.46% |
188,400
+23,200
| +14% | +$757K |
|
22
CALL
Vertex Pharmaceuticals
VRTX
$138B
| $6.81M | 0.44% |
31,100
-57,500
| -65% | -$11.6M |
|
|
FIT
23
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $6.74M | 0.44% |
1,025,498
+995,773
| +3,350% | +$5.84M |
|
24
CALL
Truist Financial
TFC
$63.1B
| $6.57M | 0.43% |
116,700
+78,900
| +209% | +$4.27M |
|
25
CALL
Texas Instruments
TXN
$236B
| $6.39M | 0.41% |
+49,800
| New | +$6.15M |
|
Similar funds
CM
SSA
UIM
CAM
Walleye Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Walleye Capital held 2,498 positions worth $1.54B, down 8.2% from $1.68B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Walleye Capital deployed $260M of net new capital in Q4 2019, opening 653 new positions and adding to 404 existing holdings. Its largest new stake was Cypress Semiconductor: 727,918 shares worth $17M.
By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, down from 94% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Humana, an estimated $2.77M trimmed.
- Walleye Capital's largest Q4 2019 buy was Cypress Semiconductor: 727,918 shares worth $17M.
- Walleye Capital added most to Acacia Communications Inc in Q4 2019, an estimated $8.45M increase.
- Walleye Capital's biggest Q4 2019 reduction was Humana, cutting an estimated $2.77M.
- Walleye Capital fully exited Cigna in Q4 2019, selling an estimated $2.57M.
- Walleye Capital's ten largest holdings make up 10% of its $1.54B portfolio in Q4 2019.
- Walleye Capital opened 653 new positions and closed 777 in Q4 2019.
- Walleye Capital's portfolio value fell 8.2% quarter-over-quarter to $1.54B.
Based on Walleye Capital's 13F filing for Q4 2019, filed 14 Feb 2020.